Bath & Body Works Hits 52-Week Low at USD 22.58 Amid Decline

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 22.58 as of November 6, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable drop in performance, with a year-to-date decline of 50.34%, contrasting sharply with the S&P 500's gain of 17.53%.
The company's financial metrics reveal a challenging landscape. With a market capitalization of USD 6,299 million, Bath & Body Works has a price-to-earnings (P/E) ratio of 7.00, indicating a low valuation relative to earnings. However, the company is facing difficulties, as evidenced by a negative return on equity and a concerning negative book value. Additionally, net sales have decreased at an annual rate of 8.28%, while operating profit has shown minimal growth.

The stock's performance has consistently lagged behind the S&P 500 over the past three years, raising concerns about its long-term viability. With a dividend yield of 3.49%, investors are closely monitoring the company's ability to navigate these financial challenges.